CCN3 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the apoptosis of K562 cells treated with CCN3 and imatinib was enhanced, suggesting that CCN3 may affect the process of cell mitosis and enhance imatinib-induced cell apoptosis in CML [49].